169 related articles for article (PubMed ID: 22902323)
1. High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation.
Chang NW; Wu CT; Chen DR; Yeh CY; Lin C
J Nutr Biochem; 2013 Jan; 24(1):274-81. PubMed ID: 22902323
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
[TBL] [Abstract][Full Text] [Related]
3. Fangchinoline induces G1 arrest in breast cancer cells through cell-cycle regulation.
Xing Z; Zhang Y; Zhang X; Yang Y; Ma Y; Pang D
Phytother Res; 2013 Dec; 27(12):1790-4. PubMed ID: 23401195
[TBL] [Abstract][Full Text] [Related]
4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
5. Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.
Bocca C; Bozzo F; Martinasso G; Canuto RA; Miglietta A
Br J Nutr; 2008 Oct; 100(4):739-50. PubMed ID: 18304389
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
[TBL] [Abstract][Full Text] [Related]
7. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells: the critical role of hEag1 channels in G1 phase progression.
Borowiec AS; Hague F; Gouilleux-Gruart V; Lassoued K; Ouadid-Ahidouch H
Biochim Biophys Acta; 2011 May; 1813(5):723-30. PubMed ID: 21315112
[TBL] [Abstract][Full Text] [Related]
8. The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
Tanaka S; Suzuki K; Sakaguchi M
Breast Cancer; 2017 Sep; 24(5):658-666. PubMed ID: 28070831
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.
Tsai SL; Suk FM; Wang CI; Liu DZ; Hou WC; Lin PJ; Hung LF; Liang YC
Biochem Pharmacol; 2007 Dec; 74(11):1575-86. PubMed ID: 17869226
[TBL] [Abstract][Full Text] [Related]
10. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.
Qin C; Burghardt R; Smith R; Wormke M; Stewart J; Safe S
Cancer Res; 2003 Mar; 63(5):958-64. PubMed ID: 12615709
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y
J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Suchanek KM; May FJ; Robinson JA; Lee WJ; Holman NA; Monteith GR; Roberts-Thomson SJ
Mol Carcinog; 2002 Aug; 34(4):165-71. PubMed ID: 12203367
[TBL] [Abstract][Full Text] [Related]
14. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
[TBL] [Abstract][Full Text] [Related]
16. A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines.
Brandi G; Paiardini M; Cervasi B; Fiorucci C; Filippone P; De Marco C; Zaffaroni N; Magnani M
Cancer Res; 2003 Jul; 63(14):4028-36. PubMed ID: 12874002
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.
Ng VY; Morisseau C; Falck JR; Hammock BD; Kroetz DL
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2462-8. PubMed ID: 16917105
[TBL] [Abstract][Full Text] [Related]
18. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
[TBL] [Abstract][Full Text] [Related]
19. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
[TBL] [Abstract][Full Text] [Related]
20. Induction of urothelial proliferation in rats by aristolochic acid through cell cycle progression via activation of cyclin D1/cdk4 and cyclin E/cdk2.
Chang HR; Lian JD; Lo CW; Chang YC; Yang MY; Wang CJ
Food Chem Toxicol; 2006 Jan; 44(1):28-35. PubMed ID: 16024155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
